PAM Medical Plasma Limited Company Accounts

PAM MEDICAL PLASMA LIMITED - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2016-07-01 Sage Accounts Production Advanced 2017 Update 2 - FRS 1,149 1,149 230 230 919 xbrli:pure xbrli:shares iso4217:GBP 10133369 2016-07-01 2017-06-30 10133369 2017-06-30 10133369 core:PlantMachinery 2016-07-01 2017-06-30 10133369 bus:Director1 2016-07-01 2017-06-30 10133369 core:WithinOneYear 2017-06-30 10133369 core:PlantMachinery 2017-06-30 10133369 core:ShareCapital 2017-06-30 10133369 core:RetainedEarningsAccumulatedLosses 2017-06-30 10133369 bus:FRS102 2016-07-01 2017-06-30 10133369 bus:AuditExempt-NoAccountantsReport 2016-07-01 2017-06-30 10133369 bus:FullAccounts 2016-07-01 2017-06-30 10133369 bus:SmallCompaniesRegimeForAccounts 2016-07-01 2017-06-30 10133369 bus:PrivateLimitedCompanyLtd 2016-07-01 2017-06-30

COMPANY REGISTRATION NUMBER: 10133369

PAM MEDICAL PLASMA LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED

30 June 2017

PAM MEDICAL PLASMA LIMITED

FINANCIAL STATEMENTS

PERIOD ENDED 30 JUNE 2017

CONTENTS	PAGE

Statement of financial position	1

Notes to the financial statements	3

PAM MEDICAL PLASMA LIMITED

STATEMENT OF FINANCIAL POSITION

30 June 2017

	2017
Note	£	£

FIXED ASSETS

Tangible assets	4		919

CURRENT ASSETS

Debtors	5	198,617
Cash at bank and in hand		111,809
		----------
		310,426

CREDITORS: Amounts falling due within one year	6	197,939
		----------
NET CURRENT ASSETS			112,487
			----------
TOTAL ASSETS LESS CURRENT LIABILITIES			113,406
			----------
NET ASSETS			113,406
			----------

CAPITAL AND RESERVES

Called up share capital		40
Profit and loss account		113,366
		----------
SHAREHOLDERS FUNDS		113,406
		----------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the period ending 30 June 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

PAM MEDICAL PLASMA LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

30 June 2017

These financial statements were approved by the board of directors and authorised for issue on 3 January 2018 , and are signed on behalf of the board by:

C Fowler

Director

Company registration number: 10133369

PAM MEDICAL PLASMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

PERIOD ENDED 30 JUNE 2017

1. GENERAL INFORMATION

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bay 4 Block D, Willenhall Trading Estate, Midacre, Willenhall, WV13 2JW, England.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. ACCOUNTING POLICIES

(a) Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. The financial statements have been prepared on the historical cost basis. (b) Revenue recognition Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, stated net of discounts. (c) Current & deferred tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. (d) Foreign currencies Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account. (e) Tangible assets Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. (f) Depreciation Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Plant and machinery	-	20% reducing balance

(g) Impairment of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

4. TANGIBLE ASSETS

	Plant and machinery
	£
Cost
Additions	1,149
	-------
At 30 June 2017	1,149
	-------
Depreciation
Charge for the period	230
	-------
At 30 June 2017	230
	-------
Carrying amount
At 30 June 2017	919
	-------

5. DEBTORS

	2017
	£
Trade debtors	198,617
	----------

6. CREDITORS: Amounts falling due within one year

	2017
	£
Trade creditors	87,288
Accruals and deferred income	2,160
Corporation tax	96,491
Other creditors	12,000
	----------
	197,939
	----------